KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Share-based Compensation (2016 - 2025)

Sarepta Therapeutics has reported Share-based Compensation over the past 15 years, most recently at -$93.4 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 232.4% year-over-year to -$93.4 million; the TTM value through Dec 2025 reached -$57700.0, down 100.03%, while the annual FY2025 figure was $14300.0, 99.99% down from the prior year.
  • Share-based Compensation for Q4 2025 was -$93.4 million at Sarepta Therapeutics, down from $14.9 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $102.9 million in Q2 2022 and troughed at -$93.4 million in Q4 2025.
  • A 5-year average of $37.3 million and a median of $41.4 million in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: surged 255.18% in 2022 and later crashed 232.4% in 2025.
  • Year by year, Share-based Compensation stood at $29.8 million in 2021, then surged by 69.6% to $50.5 million in 2022, then dropped by 9.3% to $45.8 million in 2023, then skyrocketed by 53.96% to $70.5 million in 2024, then crashed by 232.4% to -$93.4 million in 2025.
  • Business Quant data shows Share-based Compensation for SRPT at -$93.4 million in Q4 2025, $14.9 million in Q3 2025, and $37.0 million in Q2 2025.